To date, around 400,000 people in Hong Kong and nearly 38,000 Macau residents have been inoculated with the Chinese drug Sinovac and the BioNTech/Pfizer vaccine. The development comes after the recent suspension of the AstraZeneca Vaccine in multiple European countries.